Cognitive Enhancer Drugs: Market Size
The global cognitive enhancer drug market size in 2017 was approximately $4.02 billion and is expected to grow at a CAGR of 8.7% between 2018 and 2024. Pfizer, Johnson & Johnson, Novartis AG, Allergan and Takeda Pharmaceuticals are major players in the industry.
- The global cognitive enhancer drug market size was $4.02 billion in 2017.
- The Industry is expected to grow at a CAGR of 8.7% between 2018 and 2024.
- North America was the leading segment in the cognitive enhancer drugs market with more than 40% share of the total market size.
Major Players in the Cognitive Enhancer drug market
In order to provide the most recent market size of the cognitive enhancer drug, we started by combing through industry and market reports from reputable sources such as AlliedMarketResearch, Markets and Markets, WiseguyReports, Euromonitor, MarketResearch, TransparencyMarketResearch among others. We were able to find the latest information on the global market size and key players of the cognitive enhancer drug and this was cross-referenced with reports from several sources.
We couldn't provide the US market size of the cognitive enhancer drug as the information was hidden behind a paywall; hence, we have provided the global market size of the cognitive enhancer drug industry and the North American market share of the industry. The CAGR of the industry is expected to maintain steady growth between 2018 and 2024. Since the growth will extend to 2024 then the 2020 CAGR of the industry will be the same as from 2018 to 2024 which is 8.7%.